AMSL Medical supply Erwinia Asparaginase used in asparaginase therapy for treatment for Acute Lymphoblastic Leukaemia (ALL). Erwinia Asparaginase is used for remission and treatment in all paediatric and the majority of adult treatment protocols. As part of well-designed international treatment protocols long-term, event-free, survival rates in children are currently around 80% and overall survival rates are close to 90%. Adults have a poorer tolerance to some chemotherapy regimes, but overall survival rates of up to 50% are reported.

Erwinia Asparaginase plays a vital role in treatment for many people suffering from ALL thereby giving hope for a better quality of life for years to come.